文献速递肺外科

既往及同期冠状动脉血运重建后的肺移植生存结局

Lung transplant survival with past and concomitant cardiac revascularization.
PubMed 文献 · J Heart Lung Transplant · 2023-05-13

单中心回顾性分析2012年2月至2021年8月全部单肺和双肺移植患者880例,分为术前经皮冠状动脉介入、术前冠状动脉旁路移植、移植同期冠状动脉旁路移植及未血运重建四组。四组生存率无显著差异(P=0.471),术前或术中血运重建未影响肺移植患者生存结局。

要点

  • 四组肺移植患者Kaplan-Meier生存率无显著差异(P=0.471)。
  • 术前或术中血运重建未影响肺移植患者生存结局。
  • Cox回归显示诊断显著影响生存率(P=0.009)。

核心结论

  • 术前或术中血运重建未影响肺移植患者的生存结局。
  • 作者认为,部分合并冠心病的患者在接受肺移植手术期间进行干预可能获益。

研究设计与样本

  • 单中心回顾性分析2012年2月至2021年8月所有单肺和双肺移植患者,共880例。
  • 患者分为四组:术前经皮冠状动脉介入组、术前冠状动脉旁路移植组、移植同期冠状动脉旁路移植组及未血运重建组。
  • 比较四组的人口学特征、手术方式和生存结局,使用STATA软件分析,P值小于0.05认为有统计学意义。

主要发现

  • 四组间泵类型(P=0.810)、总缺血时间(P=0.994)、温缺血时间(P=0.479)、住院时间(P=0.751)和肺分配评分(P=0.332)均无显著差异。
  • 未血运重建组年龄小于其他组(P<0.01)。
  • 除未血运重建组外,各组均以特发性肺纤维化为主要诊断。
  • 术前冠状动脉旁路移植组单肺移植比例更高(P=0.014)。
  • Kaplan-Meier分析显示四组肺移植后生存率无显著差异(P=0.471);Cox回归分析显示诊断显著影响生存率(P=0.009)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronary artery disease is common among lung transplant (LTx) candidates and has historically been viewed as a contraindication to the procedure. Survival outcomes of lung transplant recipients with concomitant coronary artery disease who had prior or perioperative revascularization remain a topic of conversation. METHODS: A retrospective analysis of all single and double lung transplant patients from Feb, 2012 to Aug, 2021 at a single center was performed (n = 880). Patients were split into 4 groups: (1) those who received a preoperative percutaneous coronary intervention, (2) those who received preoperative coronary artery bypass grafting, (3) those who received coronary artery bypass grafting during transplantation, and (4) those who had lung transplantation without revascularization. Groups were compared for demographics, surgical procedure, and survival outcomes using STATA Inc. A p value< 0.05 was considered significant. RESULTS: Most patients receiving LTx were male and white. Pump type (p = 0.810), total ischemic time (p = 0.994), warm ischemic time (p = 0.479), length of stay (p = 0.751), and lung allocation score (p = 0.332) were not significantly different between the four groups. The no revascularization group was younger than the other groups (p<0.01). The diagnosis of Idiopathic Pulmonary Fibrosis was predominant in all groups except the no revascularization group. The pre-coronary artery bypass grafting group had a higher portion of single LTx procedures (p = 0.014). Kaplan-Meier analysis showed no significantly different survival rates after post-LTx between the groups (p = 0.471). Cox Regression analysis showed diagnosis significantly impacted survival rates (p 0.009). CONCLUSIONS: Preoperative or intraoperative revascularization did not affect survival outcomes in lung transplant patients. Selected patients with coronary artery disease may benefit when intervened during lung transplant procedures.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Tran T, Kashem MA, Firoz A, et al. Lung transplant survival with past and concomitant cardiac revascularization. J Heart Lung Transplant. 2023. PMID: 37187320. doi:10.1016/j.healun.2023.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。